ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 275 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,626,176 | +3197.4% | 941,755 | +3689.5% | 0.04% | +3900.0% |
| Q2 2023 | $595,206 | -95.4% | 24,852 | -95.3% | 0.00% | -95.8% |
| Q1 2022 | $12,899,000 | -71.6% | 532,557 | -37.2% | 0.02% | -90.2% |
| Q4 2020 | $45,370,000 | -3.0% | 848,679 | -25.1% | 0.25% | -17.7% |
| Q3 2020 | $46,769,000 | +382.1% | 1,133,812 | +466.5% | 0.30% | +339.7% |
| Q2 2020 | $9,701,000 | +833.7% | 200,126 | +438.3% | 0.07% | +580.0% |
| Q1 2016 | $1,039,000 | +40.6% | 37,174 | +63.9% | 0.01% | 0.0% |
| Q1 2015 | $739,000 | – | 22,686 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |